• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg
  • Home
  • Our people
  • Stockholm
  • Ola Svanberg

Ola Svanberg

  • Office: Stockholm
  • Position: Partner | Advokat
  • Areas: Corporate Compliance & Risk Corporate finance M&A Commercial dispute resolution

Ola has a broad legal background and is a member of the Capital Market Group and Public M&A. Ola specializes in capital markets and corporate law as well as dispute resolution in relation to these fields.

Ola regularly represents clients with raising capital, takeovers and squeeze-out procedures, incentive programs, corporate governance, disputes regarding sanctions and market abuse and transparency requirements.

Ola is retained Norstedts Juridik as an author of law commentary for the Market Abuse Regulation and has, together with Dennis Westermark and Monica Lagercrantz, written the book About incentive programs for Norstedts Juridik. Ola is also often engaged as an expert lecturer by listed companies, law firms, and top accounting firms.

 

Background

  • 2020– Lindahl law firm
  • 2010–2020 Advokatfirman Westermark Anjou
  • 2014 Member of the Swedish Bar Association
  • 2010 Uppsala University, LL.M.

Contact

ola.svanberg@lindahl.se +46 761 269 115 vCard

Related

  • 2/24/2023 4:19:58 PM Advokatfirman Lindahl has advised Alimak Group AB in a rights issue of approximately SEK 2,500 million
  • 2/20/2023 12:40:23 PM The Board of Directors’ information in connection with a directed share issue did not conform to good practice
  • 2/20/2023 10:40:07 AM It’s time to prepare the annual general meeting!
  • 2/17/2023 5:39:47 PM Listing Act: The European Commission proposes a simplification of prospectus regulations and the Market Abuse Regulation (MAR)
  • 1/26/2023 4:13:04 PM Lindahl legal advisor to Sedana Medical AB (publ) in connection with a change of listing to Nasdaq Stockholm
  • 10/4/2022 12:32:31 PM Lindahl assisted Polar Structure in conjunction with the public tender offer to the shareholders in Netmore
  • 7/8/2022 3:35:28 PM Lindahl advisor to Randviken Fastigheter AB (publ) in connection with the public takeover bid from Stenhus Fastigheter i Norden AB (publ)
  • 3/10/2022 12:30:15 PM Lindahl advisor to Dala Energi in connection with listing on Nasdaq First North Growth Market
  • 12/17/2021 9:41:05 AM Lindahl advisor to Randviken Fastigheter AB (publ) in a directed share issue of SEK 800 million and a listing change to Nasdaq First North Premier
  • 11/10/2021 9:59:46 AM The obligation to set up an insider list – a potential paradigm shift?
  • 10/28/2021 1:54:26 PM Lindahl has advised Clavister in the acquisition of Omen Technologies
  • 10/12/2021 10:52:45 AM News in the field of Capital Markets
  • 6/9/2021 3:26:08 PM Lindahl has advised Biosergen AB in connection with the company’s issue of units and listing on Nasdaq First North Growth Market.
  • 5/11/2021 3:55:36 PM Lindahl advisor to IDL Biotech AB in connection with public takeover bid from AroCell AB (publ)
  • 3/22/2021 3:13:01 PM Lindahl is assisting the Swedish greentech company Charge Amps AB in conjunction capital acquisition of SEK 130 million from Swedbank Robur
  • 1/27/2021 11:55:01 AM Lindahl assists the biotechnology company AegirBio in carrying out a multinational acquisition and merger
  • 10/22/2020 4:09:48 PM Lindahl assists Prevas AB in the acquisition of Evotech and subsidiaries
  • 10/9/2020 3:52:13 PM Lindahl assists Bredband2 i Scandinavia AB (plc) in a public takeover bid
  • 9/2/2020 9:53:27 AM Lindahl has advised EQT and Recover Nordic in the acquisition of MISAB Gruppen
  • 6/29/2020 3:59:04 PM Lindahl assists ISR Immune System Regulation Holding in a targeted new share issue worth MSEK 5
  • 6/1/2020 4:41:50 PM Lindahl represents Aegirbio in rights issue of units prior too listing on Nasdaq First North Growth Market
  • 5/6/2020 5:17:13 PM Lindahl assists ISR Immune System Regulation Holding in a rights issue of approximately SEK 71.7 million

Search employee

315 employees
  • Johan Åberg johan.aberg@lindahl.se +46 761 269 105
  • Felicia Åberg felicia.aberg@lindahl.se +46 723 571 456
  • David Ackebo david.ackebo@lindahl.se +46 701 474 119
  • Anders Adielsson anders.adielsson@lindahl.se +46 730 399 253
  • Tobias Adolfsson
  • Philip Ahl philip.ahl@lindahl.se +46 731 472 711
  • Gustav Ahlgren gustav.ahlgren@lindahl.se +46 734 158 215
  • Disa Almqvist disa.almqvist@lindahl.se +46 708 621 453
  • Simon Alsing simon.alsing@lindahl.se +46 723 937 521
  • Sara Andersson sara.andersson@lindahl.se +46 709 896 523
  • Annika Andersson annika.andersson@lindahl.se +46 730 399 240
  • Ida Andersson
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience